Trials / Not Yet Recruiting
Not Yet RecruitingNCT07521202
IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE
A Scientific Study Evaluating Therapy Persistence in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer Under Adjuvant Treatment With Abemaciclib Who Receive Standardized Patient Education and Counselling.
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 257 (estimated)
- Sponsor
- Institut fuer Frauengesundheit · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this interventional study is to evaluate the effect of standardized patient coaching on treatment adherence among patients taking abemaciclib. The main question it aims to answer is, whether standardized coaching leads to patients taking abemaciclib much more consistently. Researchers will therefore compare therapy adherence of patients receiving standardized coaching to patients receiving routine care. Participants will be asked to answer several questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standardized patient coaching | Standardized patient coaching based on the Multinational Association of Supportive Care in Cancer (MASCC) Oral Agent Teaching Tool© (MOATT) |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2029-06-01
- Completion
- 2030-06-01
- First posted
- 2026-04-09
- Last updated
- 2026-04-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07521202. Inclusion in this directory is not an endorsement.